BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 13, 2003
View Archived Issues
HGS Gains Exclusive License From Abgenix For CCR5 MAb
Human Genome Sciences Inc. exclusively licensed rights from Abgenix Inc. to develop a fully human monoclonal antibody to the CCR5 receptor, for which Abgenix earns an undisclosed milestone payment. (BioWorld Today)
Read More
Genentech, XOMA Stop Trial In RA Because Of Lack Of Efficacy
Read More
Epimmune Enters Agreement For $13.5M Stock Merger With Anosys
Read More
Blue Heron Making Waves With Products For Gene Synthesis
Read More
BIO Asks Congress To Revisit Rule On Reimbursement Rates
Read More
Other News To Note
Read More
Appointments And Advancements
Read More